CHARACTERIZATION OF HUMORAL AND CD4(-RESPONSES AFTER GENETIC IMMUNIZATION WITH RETROVIRAL VECTORS EXPRESSING DIFFERENT FORMS OF THE HEPATITIS-B VIRUS CORE AND E-ANTIGENS() CELLULAR)
M. Sallberg et al., CHARACTERIZATION OF HUMORAL AND CD4(-RESPONSES AFTER GENETIC IMMUNIZATION WITH RETROVIRAL VECTORS EXPRESSING DIFFERENT FORMS OF THE HEPATITIS-B VIRUS CORE AND E-ANTIGENS() CELLULAR), Journal of virology, 71(7), 1997, pp. 5295-5303
The humoral and CD4(+) cellular immune responses in mice following gen
etic immunization with three retroviral vectors encoding different for
ms of hepatitis B virus core antigen (HBcAg) and e antigen (HBeAg) wer
e analyzed, The retroviral vectors induced expression of intracellular
HBcAg (HBc[3A4]), secreted HBeAg (HEe[5A2]), or an intracellular HBcA
g-neomycin phosphoryltransferase fusion protein (HBc-NEO[6A3]), Specif
ic antibody levels and immunoglobulin G isotype restriction were highl
y dependent on both the host major histocompatibility complex and the
transferred gene, Humoral and CD4(+) cellular HBcAg and/or HBeAg (HBc/
eAg)-specific immune responses following retroviral vector immunizatio
n were of a lower magnitude but followed the same characteristics comp
ared with those after immunization with HBc/eAg in adjuvant, Two facto
rs influenced the humoral responses, First, in vivo depletion of CD8() cells in HBc-NEO [6A3]-immunized H-2(k) mice abrogated both HBcAg-sp
ecific antibodies and in vitro-detectable cytotoxic T lymphocytes. Sec
ond, priming of H-2(b) mice with an HBc/eAg-derived T-helper (Th) pept
ide in adjuvant prior to retroviral vector immunization greatly enhanc
ed the HBc/eAg-specific humoral responses to all three vectors, sugges
ting that insufficient HBc/eAg-specific CD4(+) Th-cell priming limits
the humoral responses, In conclusion, direct injection of retroviral v
ectors seems to be effective in priming HBc/eAg-specific CD8(+) but co
mparatively inefficient in priming CD4(+) Th cells and subsequently sp
ecific antibodies, However, the limited HBc/eAg-specific CD4(+) cell p
riming can effectively be circumvented by prior administration of a re
combinant or synthetic form of HBc/eAg in adjuvant.